Masami Nonaka

Optimization of (2,3-Dihydro-1-benzofuran-3-yl)acetic Acids: Discovery of a Non-Free Fatty Acid-Like, Highly Bioavailable G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist as a Glucose-Dependent Insulinotropic Agent

Nobuyuki Negoro, Shinobu Sasaki, Satoshi Mikami et al. · Journal of Medicinal Chemistry · 2012 · 73 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

<i>In vitro</i> metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker

Hitomi Yamasaki, Naohiro Kawaguchi, Masami Nonaka et al. · Xenobiotica · 2016 · 66 citations

Medicine, Pharmacokinetics, Pharmacology +15

Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogs

Akifumi Kogame, Toshiyuki Takeuchi, Masami Nonaka et al. · Xenobiotica · 2016 · 18 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Disposition and metabolism of the G protein-coupled receptor 40 agonist TAK-875 (fasiglifam) in rats, dogs, and humans

Akifumi Kogame, Ronald Lee, Liping Pan et al. · Xenobiotica · 2018 · 16 citations

Medicine, Pharmacokinetics, Pharmacology +13

Studies on Non-Thiazolidinedione Antidiabetic Agents. 3. Preparation and Biological Activity of the Metabolites of TAK-559

Hiroshi Imoto, Mitsuharu Matsumoto, Hiroyuki Odaka et al. · Chemical and Pharmaceutical Bulletin · 2004 · 10 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12